- Home
- IMNM vs EMO Comparison
IMNM vs EMO Comparison
Compare IMNM & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- EMO
- Stock Information
- Founded
- IMNM 2006
- EMO 2011
- Country
- IMNM United States
- EMO United States
- Employees
- IMNM N/A
- EMO N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- EMO Investment Managers
- Sector
- IMNM Health Care
- EMO Finance
- Exchange
- IMNM Nasdaq
- EMO Nasdaq
- Market Cap
- IMNM 542.6M
- EMO 599.1M
- IPO Year
- IMNM 2020
- EMO N/A
- Fundamental
- Price
- IMNM $7.91
- EMO $44.93
- Analyst Decision
- IMNM Strong Buy
- EMO
- Analyst Count
- IMNM 6
- EMO 0
- Target Price
- IMNM $26.00
- EMO N/A
- AVG Volume (30 Days)
- IMNM 1.7M
- EMO 27.1K
- Earning Date
- IMNM 05-13-2025
- EMO 01-01-0001
- Dividend Yield
- IMNM N/A
- EMO 6.70%
- EPS Growth
- IMNM N/A
- EMO N/A
- EPS
- IMNM N/A
- EMO N/A
- Revenue
- IMNM $9,041,000.00
- EMO N/A
- Revenue This Year
- IMNM N/A
- EMO N/A
- Revenue Next Year
- IMNM $1,259.12
- EMO N/A
- P/E Ratio
- IMNM N/A
- EMO N/A
- Revenue Growth
- IMNM N/A
- EMO N/A
- 52 Week Low
- IMNM $5.15
- EMO $26.42
- 52 Week High
- IMNM $19.07
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- IMNM 55.28
- EMO 45.02
- Support Level
- IMNM $6.96
- EMO $40.04
- Resistance Level
- IMNM $7.56
- EMO $43.95
- Average True Range (ATR)
- IMNM 0.69
- EMO 2.18
- MACD
- IMNM 0.26
- EMO -0.14
- Stochastic Oscillator
- IMNM 98.22
- EMO 48.13
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.